Rafferty Asset Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,261
Closed -$12K 1267
2022
Q1
$12K Sell
1,261
-741
-37% -$11.3K ﹤0.01% 1216
2021
Q4
$43K Buy
+2,002
New +$53.5K ﹤0.01% 1291

Other funds holding SRGA

Rafferty Asset Management's SRGA Position: Q2 2022 in Review

Rafferty Asset Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 1,261 shares — an estimated $12K sold.

Rafferty Asset Management first reported a position in SRGA in Q4 2021 and held it in 2 quarters. The position peaked at $43K in Q4 2021. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.

  • Rafferty Asset Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 1,261 Surgalign Holdings, Inc. Common Stock shares in Q2 2022, an estimated $12K.
  • Rafferty Asset Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Rafferty Asset Management's Surgalign Holdings, Inc. Common Stock position peaked at $43K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.

Based on Rafferty Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.